ClinicalTrials.Veeva
Menu

Find clinical trials for Multiple Sclerosis (MS) in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Sclerosis
Multiple Sclerosis
Relapsing-Remitting Multiple Sclerosis
Chronic Progressive Multiple Sclerosis
Amyotrophic Lateral Sclerosis
Motor Neuron Disease
Muscle Spasticity

Multiple Sclerosis (MS) trials near San Antonio, TX, USA:

Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...

Enrolling
Multiple Sclerosis
Drug: Placebo capsule
Drug: Fingolimod

Phase 3

Novartis
Novartis

San Antonio, Texas, United States and 107 other locations

This study will evaluate the impact of ofatumumab in Relapsing Remitting Multiple Sclerosis (RRMS) participants that are very early...

Active, not recruiting
Relapse Remitting Multiple Sclerosis
Drug: Ofatumumab

Phase 4

Novartis
Novartis

San Antonio, Texas, United States and 35 other locations

(maintenance) in people with systemic lupus erythematosus (lupus), infantile spasms, adults with acute relapses or flares of multiple sclerosis...

Enrolling
Scleritis
Drug: ACTH (adrenocorticotropic hormone) gel

Phase 2

Metropolitan Eye Research & Surgery Institute

San Antonio, Texas, United States and 2 other locations

Recently updated

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...

Enrolling
Relapsing Multiple Sclerosis
Drug: Remibrutinib
Drug: Teriflunomide

Phase 3

Novartis
Novartis

San Antonio, Texas, United States and 229 other locations

The primary objectives are to investigate the safety and tolerability of BIIB091 monotherapy in participants with relapsing multiple sclerosis...

Enrolling
Relapsing Forms of Multiple Sclerosis
Drug: BIIB091
Drug: DRF

Phase 2

Biogen
Biogen

San Antonio, Texas, United States and 73 other locations

for the overall conduct of the study at the site, confirmation of subject eligibility, routine study subject clinical management including for MS...

Active, not recruiting
Multiple Sclerosis
Drug: RPC-1063

Phase 3

Celgene
Celgene

San Antonio, Texas, United States and 60 other locations

assess the safety, tolerability, and pharmacokinetics of single and multiple ascending oral doses of prosetin administered to healthy adult ...

Enrolling
Amyotrophic Lateral Sclerosis
Drug: placebo
Drug: prosetin

Phase 1

ProJenX

San Antonio, Texas, United States

The purpose of this study is to evaluate long-term safety and efficacy of ublituximab therapy in participants with relapsing multiple sclerosis...

Active, not recruiting
Relapsing Multiple Sclerosis (RMS)
Biological: Ublituximab

Phase 3

TG Therapeutics
TG Therapeutics

San Antonio, Texas, United States and 85 other locations

This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sc...

Active, not recruiting
Progressive Multiple Sclerosis (PMS)
Drug: Ocrelizumab

Phase 3

Roche
Roche

San Antonio, Texas, United States and 125 other locations

Locations recently updated

in male and female participants with relapsing forms of multiple sclerosis (aged 18 to 55 years at the time of enrollment). People ...

Enrolling
Multiple Sclerosis
Drug: Activated charcoal
Drug: Cholestyramine

Phase 3

Sanofi
Sanofi

San Antonio, Texas, United States and 69 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems